PUBLISHER: The Business Research Company | PRODUCT CODE: 1485192
PUBLISHER: The Business Research Company | PRODUCT CODE: 1485192
Process analytical technology (PAT) is a structured approach utilized in the design, analysis, and management of manufacturing processes. It involves the real-time measurement of critical process parameters (CPPs) and quality attributes. PAT is integral to contemporary manufacturing operations as it facilitates continuous monitoring, analysis, and control of manufacturing processes. By ensuring consistent product quality, enhancing efficiency, and minimizing production costs, PAT significantly contributes to the optimization of manufacturing processes.
The primary products within the realm of process analytical technology (PAT) encompass analyzers, sensors and probes, samplers, as well as software and associated services. Analyzers serve as instruments utilized to assess and measure diverse properties of substances or materials, offering critical insights into their composition, quality, and attributes. Employing various techniques such as spectroscopy, chromatography, particle size analysis, electrophoresis, among others, analyzers find application across numerous sectors including small molecules, large molecules, manufacturing processes, and others. These products are utilized by a wide array of end-users including pharmaceutical companies, biotechnology firms, and other relevant industries.
The process analytical technology market research report is one of a series of new reports from The Business Research Company that provides process analytical technology market statistics, including process analytical technology industry global market size, regional shares, competitors with a process analytical technology market share, detailed process analytical technology market segments, market trends and opportunities, and any further data you may need to thrive in the process analytical technology industry. This process analytical technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The process analytical technology market size has grown rapidly in recent years. It will grow from $2.68 billion in 2023 to $2.99 billion in 2024 at a compound annual growth rate (CAGR) of 11.6%. The growth observed in the historic period can be attributed to several factors including regulatory compliance obligations, stringent quality control requirements, initiatives aimed at reducing costs, the globalization of supply chains, and heightened market competition.
The process analytical technology market size is expected to see rapid growth in the next few years. It will grow to $4.68 billion in 2028 at a compound annual growth rate (CAGR) of 11.9%. The projected growth in the forecast period can be attributed to various factors including sustainability initiatives, the rising prominence of personalized medicine trends, integration with Industry 4.0 technologies, expansion into emerging markets, and a shift towards continuous manufacturing practices. Major trends anticipated in the forecast period include the adoption of remote monitoring technologies, a heightened focus on data analytics and artificial intelligence (AI), the expansion of digital twins for process optimization, the integration of blockchain technology to enhance supply chain transparency, and the emergence of personalized manufacturing approaches.
The increasing demand for personalized medicine is poised to drive the growth of the process analytical technology (PAT) market. Personalized medicine, which tailors medical treatments based on individual genetic, environmental, and lifestyle factors, is gaining traction due to advancements in genomics. Process analytical technology plays a crucial role in personalized medicine by monitoring and analyzing critical parameters during the manufacturing of personalized treatments, ensuring precise control over the production process to maintain the quality and consistency of individualized therapies. For instance, in 2022, the FDA's Center for Drug Evaluation and Research (CDER) reported that a significant portion of newly approved molecular entities (NMEs) were classified as personalized medicines, highlighting the increasing integration of personalized medicine into pharmaceutical development and regulatory approvals.
Key players in the process analytical technology market are focusing on innovation to gain a competitive edge. One such innovation is the development of new compact radiance instruments, which enable high-resolution characterization of cellular heterogeneity, responses, and behavior in real time during manufacturing processes. For example, LumaCyte Inc. launched a compact radiance instrument designed for advanced therapy biomanufacturing and quality control environments in October 2023. This instrument, equipped with high-content, label-free microfluidic cell analysis and sorting capabilities, occupies minimal bench space while offering advanced analytical functionality. Such technological advancements are instrumental in enhancing efficiency and precision in biomanufacturing and quality control operations.
In January 2024, Bruker Corporation expanded its biopharma process analytical technology (PAT) product portfolio through the acquisition of Tornado Spectral Systems Inc. This strategic move enhances Bruker's capabilities in pharma and biotech quality control applications by incorporating Tornado's innovative Raman instruments. Tornado Spectral Systems Inc., known for its expertise in analytical instrumentation, complements Bruker's offerings, strengthening its position in the process analytical technology market and enabling further advancements in pharmaceutical manufacturing and quality assurance.
Major companies operating in the process analytical technology market are Siemens AG, Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd., GE Healthcare, Emerson Electric Co., Agilent Technologies Inc., Teledyne Technologies Incorporated, Sartorius AG, Mettler-Toledo, PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd., Carl Zeiss AG, Nova Biomedical, TECAN Group Ltd., Repligen Corporation, Hamilton Company, Oxford Instruments plc, Malvern Panalytical, Hitachi High-Tech Analytical Science, JEOL Ltd., Yokogawa Electric Corporation
North America was the largest region in the process analytical technology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the process analytical technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the process analytical technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The process analytical technology market consists of revenues earned by entities by providing services such as consulting services, custom development services, training and education, and customization and integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The process analytical technology market also includes sales of spectrometers, chromatography systems, process control software, and data management and integration platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.